A simpler heart scan could catch cancer treatment side effects
NCT ID NCT06310330
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether a simplified heart ultrasound is as good as the standard comprehensive exam for detecting heart problems caused by breast cancer treatment. About 250 breast cancer patients will be randomly assigned to one of the two monitoring approaches. The study also explores whether automated measurements can make heart scans more precise in everyday practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Simplified echocardiographic follow-up compared with comprehensive echocardiographic follow-up
- What this could lead to
- If it works, a quicker, simpler heart ultrasound could reliably detect heart problems caused by breast cancer treatment, making monitoring easier for patients and clinics.
- What could go wrong
- The simplified approach may miss subtle heart changes that the full exam catches, and the trial's findings may not apply to all breast cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM MALIGNANT PRIMARY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Olavs hospital
RECRUITINGTrondheim, 7491, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.